Table of Content


Introduction
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Overview
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Therapeutics Development
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Therapeutics Assessment
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Companies Involved in Therapeutics Development
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Drug Profiles
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Dormant Products
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by Annji Pharmaceutical Co Ltd, 2021
Pipeline by ATP Biopharm, 2021
Pipeline by Augustine Therapeutics, 2021
Pipeline by Beijing Konruns Pharmaceutical Co Ltd, 2021
Pipeline by Bristol Myers Squibb Co, 2021
Pipeline by Chong Kun Dang Pharmaceutical Corp, 2021
Pipeline by Convalife, 2021
Pipeline by CStone Pharmaceuticals Co Ltd, 2021
Pipeline by Curis Inc, 2021
Pipeline by Eikonizo Therapeutics Inc, 2021
Pipeline by Guangdong Zhongsheng Pharmaceutical Co Ltd, 2021
Pipeline by Hillstream BioPharma Inc, 2021
Pipeline by Jubilant Therapeutics Inc, 2021
Pipeline by Kancera AB, 2021
Pipeline by Karus Therapeutics Ltd, 2021
Pipeline by KYAN Therapeutics Inc, 2021
Pipeline by Medivir AB, 2021
Pipeline by Merck & Co Inc, 2021
Pipeline by Mycovia Pharmaceuticals Inc, 2021
Pipeline by OnKure Inc, 2021
Pipeline by Oryzon Genomics SA, 2021
Pipeline by Quimatryx SL, 2021
Pipeline by Shuttle Pharmaceuticals Inc, 2021
Pipeline by SK Biopharmaceuticals Co Ltd, 2021
Pipeline by Starwise Therapeutics LLC, 2021
Pipeline by Tenaya Therapeutics Inc, 2021
Dormant Products, 2021